Proteomic identification of differentially expressed plasma membrane proteins in renal cell carcinoma by stable isotope labelling of a von Hippel-Lindau transfectant cell line model-Reference-Cited by-同舟云学术

Proteomic identification of differentially expressed plasma membrane proteins in renal cell carcinoma by stable isotope labelling of a von Hippel-Lindau transfectant cell line model

Published:2009-03-31 Issue:8 Volume:9 Page:2118-2130
ISSN:1615-9853
Container-title:PROTEOMICS
language:en
Short-container-title:Proteomics

Author:

Aggelis Vassilis,Craven Rachel A.,Peng Jianhe,Harnden Patricia,Cairns David A.,Maher Eamonn R.,Tonge Robert,Selby Peter J.,Banks Rosamonde E.

Funder

Cancer Research UK

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pmic.200800756/fullpdf

Reference73 articles.

1. Global cancer statistics;Parkin;CA Cancer J. Clin.,2002

2. Recurrence of renal cell carcinoma more than 5 years after nephrectomy;Uchida;Int. J. Urol.,2002

3. Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma;Fisher;Cancer J. Sci. Am.,2000

4. Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: An Eastern Cooperative Oncology Group/Intergroup trial;Messing;J. Clin. Oncol.,2003

5. The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma;Kaelin;Clin. Cancer Res.,2007

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of plasma membrane proteomics to identify cancer biomarkers;Proteomics;2023

2. Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker–driven learning framework;Science Advances;2022-09-30

3. Proteome Analysis of S-Palmitoylation Modification in Clear Cell Renal Cell Carcinoma;CHINESE J ANAL CHEM;2021

4. Maximized quantitative phosphoproteomics allows high confidence dissection of the DNA damage signaling network;Scientific Reports;2020-10-22

5. Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion;British Journal of Cancer;2020-05-11